# Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy

> **NCT04913376** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 66 (actual)

## Conditions studied

- Quality of Life
- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DEVICE:** Hilotherapy

## Key facts

- **NCT ID:** NCT04913376
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-17
- **Primary completion:** 2022-10-25
- **Final completion:** 2022-10-25
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913376, "Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04913376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*